Deprecated: uasort(): Returning bool from comparison function is deprecated, return an integer less than, equal to, or greater than zero in /var/www/html/wp-content/plugins/google-site-kit/includes/Core/Modules/Modules.php on line 245 Warning: Cannot modify header information - headers already sent by (output started at /var/www/html/wp-content/plugins/google-site-kit/includes/Core/Modules/Modules.php:245) in /var/www/html/wp-includes/rest-api/class-wp-rest-server.php on line 1893 {"id":3543,"date":"2020-04-06T02:11:10","date_gmt":"2020-04-06T06:11:10","guid":{"rendered":"https:\/\/cannalogue.ca\/column\/?p=3543"},"modified":"2020-04-06T10:04:13","modified_gmt":"2020-04-06T14:04:13","slug":"cannalogue-introduces-covid-19-compassionate-care-program-for-medical-cannabis","status":"publish","type":"post","link":"https:\/\/cannalogue.ca\/column\/newsroom\/compassionate-care-clinical-trial","title":{"rendered":"Cannalogue Introduces COVID-19 Compassionate Care Program For Medical Cannabis"},"content":{"rendered":"

Physician-led online marketplace offers discount of 20-50% on select products for frontline workers, seniors and financially strained<\/em><\/p>\n

TORONTO, ON \u2013 April 6, 2020:<\/strong> \u00a0As a response to the closure of storefront retailers due to COVID-19, online marketplace Cannalogue<\/a> announced today a new Compassionate Care<\/em> Program<\/em><\/a> that seeks to provide better access to medical cannabis for all Canadians.<\/p>\n

Qualified candidates including first responders, seniors (aged 60+), nurses, teachers, and those facing financial strain due to work shortage\/layoffs can enroll in the program to receive a selection of products at a discount of 20-50%.\u00a0 The doctor-recommended, Health Canada approved products include oils, gel capsules, and dried flowers from as low as $3.50\/gram.\u00a0 As the most inclusive program in Canada, Cannalogue\u2019s Compassionate Care Program<\/a> is also available to veterans, individuals currently enrolled in a disability, federal or provincial assistance program, and Indigenous peoples.<\/p>\n

\u201cCOVID-19 has had a devastating effect on all Canadians\u201d says President and CEO, Dr. Mohan Cooray. \u201cAs a result, we\u2019ve seen an upsurge in cannabis use among patients managing symptoms such as pain, anxiety, difficulty sleeping, and stress \u2013 especially from symptoms related to COVID-19 isolation.\u00a0 Cannabis is a natural plant medicine that can be used safely to manage mental health issues without the dependency effects we see from alcohol, opioids or narcotics.\u00a0 During this unprecedented time and without access to storefront retailers, we want to help Canadians receive the products they need,\u201d he says.<\/p>\n

Additionally, with limited access to doctors or pharmacists during self-isolation, Cannalogue\u2019s medical staff can assess and provide dosage recommendations over the phone.\u00a0 \u201cCannalogue is an essential national medical service that Health Canada has confirmed will be fully available to patients during the pandemic. No matter how long we face the challenges of COVID-19, Cannalogue will be here to help,\u201d says Dr. Cooray.<\/p>\n

To learn more about Cannalogue\u2019s COVID-19 Compassionate Care Program<\/em><\/a> or to enroll, click here<\/a>.<\/p>\n

<\/p>\n

About Cannalogue<\/u><\/strong>:<\/strong>
\nBased in Toronto, Cannalogue is a rapidly emerging healthcare technology company that received Health Canada’s first direct-to-sales licence for medical cannabis. Cannalogue’s innovative technology provides a safe, controlled, and cost-effective online marketplace that is globally scalable into all medical cannabis markets.\u00a0 Engineered by physicians Dr. Mohan Cooray and Dr. Andrew Lu, Cannalogue challenges the status quo and advocates on behalf of patients to educate medical professionals and government officials on the safety and benefits of medical cannabis as a viable treatment option to traditional therapies.<\/p>\n","protected":false},"excerpt":{"rendered":"